Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF

R&D Systems | Catalog # 3888-SE

Analyzed by SEC-MALS
R&D Systems
Loading...

Key Product Details

  • R&D Systems NS0-derived Recombinant Human Proprotein Convertase 9/PCSK9 Protein (3888-SE)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

NS0

Accession Number

Structure / Form

Mature form & pro domain

Applications

Bioactivity
Loading...

Product Specifications

Source

Mouse myeloma cell line, NS0-derived human Proprotein Convertase 9/PCSK9 protein
Gln31-Gln152 & Ser153-Gln692, with a C-terminal 10-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ser153 (mature form); No results obtained for pro domain, Gln31 inferred from enzymatic pyroglutamate treatment revealing Glu32

Predicted Molecular Mass

14 kDa & 59 kDa

SDS-PAGE

19 kDa & 66 kDa, reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Human LDL R (Catalog # 2148-LD) is coated at 2 µg/mL, Recombinant Human Proprotein Convertase 9/PCSK9 binds with an ED50 of 70-420 ng/mL.

Reviewed Applications

Read 1 review rated 5 using 3888-SE in the following applications:

Scientific Data Images for Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF

Recombinant Human Proprotein Convertase 9/PCSK9 SEC-MALS.

Recombinant Human Proprotein Convertase 9/PCSK9 (Catalog # 3888-SE) has a molecular weight (MW) of 74-82 kDa as analyzed by SEC-MALS, suggesting that this protein is a monomer. MW may differ from predicted MW due to post-translational modifications (PTMs) present (i.e. Glycosylation).
Recombinant Human Proprotein Convertase 9/PCSK9 Protein Binding Activity

Recombinant Human Proprotein Convertase 9/PCSK9 Protein Binding Activity

When Recombinant Human LDL R (Catalog # 2148-LD) is coated at 2 µg/mL, Recombinant Human Proprotein Convertase 9/ PCSK9 (Catalog # 3888-SE) binds with an ED50 of 70-420 ng/mL.

Formulation, Preparation, and Storage

3888-SE
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl and Glycerol.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: Proprotein Convertase 9/PCSK9

The human PCSK9 gene encodes Proprotein Convertase 9 (PC9), which is also known as Neural Apoptosis Regulated Convertase 1 (NARC1) (1). The deduced amino acid sequence of human PCSK9 consists of a signal peptide (residues 1 to 30), a pro peptide (residue 31 to 152), and a mature chain (residues 153 to 692) that contains a serine protease domain (residues 161 to 431) found in members of the furin/PC family. PCSK9 protease activity may be limited, since it has only been demonstrated through its own autocatalytic processing (2). After the autocleavage in the ER, the pro domain and mature chain exit the cell together through non‑covalent interactions (3). PCSK9 is a key regulator of LDL-cholesterol levels (LDL-C) through binding of the LDL receptor, resulting in the reduction of receptor recycling to the cell surface and the acceleration of receptor degradation in lysosomes (3). Both gain of function (GOF) and loss-of-function (LOF) mutations have been found in the PCSK9 gene (3). GOF mutations are linked to familial autosomal dominant hypercholesterolemia, a disease characterized by elevated plasma levels of LDL-C. In comparison, LOF mutations lead to low levels of LDL-C and protection against coronary heart disease.

References

  1. Seidah, N.G. et al. (2003) Proc. Natl. Acad. Sci. USA 100:928.
  2. Naureckiene, S. et al. (2003) Arch. Biochem. Biophys. 420:55.
  3. Costet, P. et al. (2008) Trends Biochem. Sci. 33:426.

Alternate Names

FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1, PC9, PCSK9

Entrez Gene IDs

255738 (Human); 100102 (Mouse); 298296 (Rat); 102142788 (Cynomolgus Monkey)

Gene Symbol

PCSK9

UniProt

Additional Proprotein Convertase 9/PCSK9 Products

Product Documents for Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF

For research use only

Related Research Areas

Citations for Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF

Customer Reviews for Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF (1)

5 out of 5
1 Customer Rating
5 Stars
100%
4 Stars
0%
3 Stars
0%
2 Stars
0%
1 Stars
0%

Have you used Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card
Showing  1 - 11 review Showing All
Filter By:
  • Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF
    Name: Nicole Thomas
    Application: Binding assay/Protein-protein interaction
    Verified Customer | Posted 04/25/2019

There are no reviews that match your criteria.

Showing  1 - 11 review Showing All

FAQs for Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF

Showing  1 - 22 FAQs Showing All
  • Q: Does Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF (Catalog # 3888-SE) include only the active form of the protein?

    A: Catalog # 3888-SE is supplied as a mixture of the pro domain and the mature (active) form. The sequence is Gln31­-Gln152 (pro domain) & Ser153-­Gln692 (mature form), with a C­-terminal 10­-His tag. This sequence is based on Accession # Q8NBP7.

  • Q: Has R&D Systems evaluated the ratio of the pro domain and the mature form in the final product of Human Proprotein Convertase 9/PCSK9 Protein, CF (Catalog # 3888-SE)?

    A: The pro domain is the small region cleaved from the mature form. Catalog # 3888-SE undergoes autocleavage during processing to separate the pro domain and the mature form, but these remain non-covalently associated. While we have not empirically evaluated the relative levels of the pro domain and the mature form, we would expect a molar ratio of approximately 1:1.

  • Q: Does Recombinant Human Proprotein Convertase 9/PCSK9 Protein, CF (Catalog # 3888-SE) include only the active form of the protein?

    A: Catalog # 3888-SE is supplied as a mixture of the pro domain and the mature (active) form. The sequence is Gln31­-Gln152 (pro domain) & Ser153-­Gln692 (mature form), with a C­-terminal 10­-His tag. This sequence is based on Accession # Q8NBP7.

  • Q: Has R&D Systems evaluated the ratio of the pro domain and the mature form in the final product of Human Proprotein Convertase 9/PCSK9 Protein, CF (Catalog # 3888-SE)?

    A: The pro domain is the small region cleaved from the mature form. Catalog # 3888-SE undergoes autocleavage during processing to separate the pro domain and the mature form, but these remain non-covalently associated. While we have not empirically evaluated the relative levels of the pro domain and the mature form, we would expect a molar ratio of approximately 1:1.

Showing  1 - 22 FAQs Showing All
View all FAQs for Proteins and Enzymes
Loading...